"10.1371_journal.pone.0027252","plos one","2011-11-09T00:00:00Z","Kimberly Mattia; Bridget A Puffer; Katherine L Williams; Ritela Gonzalez; Meredith Murray; Emily Sluzas; Dan Pagano; Sandya Ajith; Megan Bower; Eli Berdougo; Eva Harris; Benjamin J Doranz","Integral Molecular, Inc., Philadelphia, Pennsylvania, United States of America; Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, California, United States of America","Conceived and designed the experiments: KM BAP KLW EH BJD. Performed the experiments: KM BAP KLW RG MM ES DP SA MB. Analyzed the data: KM BAP KLW EB EH BJD. Wrote the paper: KM BAP KLW EB EH BJD.","The authors have read the journal's policy and have the following conflicts. Integral Molecular, Inc. offers Dengue Reporter Virus Particles as a commercial product and has filed a patent (Patent Application # 12/942632) that describes how Dengue RVPs are made. KM, BP, MM, ES, DP, SA, MB, EB, and BJD are all employees of Integral Molecular. BJD is a shareholder of Integral Molecular. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.","2011","11","Kimberly Mattia","KM",12,TRUE,5,9,6,6,TRUE,TRUE,FALSE,0,NA,FALSE
